Abstract
This study compared the immune responses of healthy children to one or two doses of Oka/Merck varicella vaccine. Both cell-mediated and humoral immune responses were significantly stronger 1 year later among children given two doses 3 months apart than among those given a single dose. Long-term follow-up studies are needed to determine whether two doses of vaccine indeed provide more complete and more durable protection than a single dose against breakthrough varicella in healthy children.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Viral / biosynthesis*
-
Chickenpox / immunology*
-
Chickenpox / prevention & control
-
Chickenpox Vaccine
-
Child
-
Child, Preschool
-
Female
-
Herpesvirus 3, Human / immunology*
-
Humans
-
Immunity, Cellular
-
Immunization Schedule
-
Infant
-
Lymphocyte Activation / immunology
-
Male
-
Vaccines, Attenuated / administration & dosage*
-
Vaccines, Attenuated / immunology
-
Viral Vaccines / administration & dosage*
-
Viral Vaccines / immunology
Substances
-
Antibodies, Viral
-
Chickenpox Vaccine
-
Vaccines, Attenuated
-
Viral Vaccines